Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 2/20 | 0.34 |
| ▸ | TLR8 | Q9NR97 | 5/20 | 0.34 |
| ▸ | TLR7 | Q9NYK1 | 5/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 3/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22431673 | 0.74 | CSNK2A1 (0.38) | TLR8TLR7KMT2ARXFP1MAPT | |
| SCHEMBL24853807 | 0.71 | ALDH1A1 (0.42) | TP53KMT2ARXFP1MAPTMEN1 | |
| SCHEMBL24853587 | 0.69 | ALDH1A1 (0.36) | TP53KMT2AMAPTMEN1ELANE | |
| SCHEMBL24853790 | 0.69 | GPR3 (0.36) | TP53KMT2ARXFP1MAPTMEN1 | |
| SCHEMBL24853596 | 0.69 | ALDH1A1 (0.36) | TLR8KMT2AMAPTMEN1NPC1 | |
| SCHEMBL24854103 | 0.68 | PRMT5 (0.40) | TP53MAPTNPC1RAB9ALMNA | |
| SCHEMBL793629 | 0.68 | NQO2 (0.36) | TLR8TLR7KMT2AMAPTMEN1 | |
| SCHEMBL24854100 | 0.66 | GPR3 (0.36) | TP53KMT2AMAPTRAB9ACYP1A2 | |
| SCHEMBL24853582 | 0.65 | TLR8 (0.41) | TLR8TLR7ELANESMN1; SMN2 | |
| SCHEMBL24853603 | 0.63 | PRMT5 (0.38) | TP53KMT2AMAPTMEN1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230002427-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | LG DISPLAY CO., LTD. (KR) | 2023-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230002427-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | NONO, BMI1, LIG1 | TP53 3809/4885TLR8 4464/4885TLR7 2265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.